![]() F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | ![]() Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. | |
Founding Date | Founding Date 2006 | Founding Date 2013 |
Type | Type Private | Type Subsidiary |
Tags | ||
Locations | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US |
Employees | Employees 39 | Employees 1091% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) $111.9m (FY, 2017) |
Net income | Net income (£2.6m) (FY, 2018) | Net income ($437.1m) (FY, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 57.3m | Total funding raised $ 310m |

Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
View company